108 AACR CANCER PROGRESS REPORT 2017
Condition Generic Name Trade Name
Breast cancer raloxifene Evista
tamoxifen Nolvadex
Cervical, vulvar, vaginal, and anal human papillomavirus quadrivalent Gardasil
cancers and dysplasia; genital warts vaccine (Types 6, 11, 16, and 18)
Cervical, vulvar, vaginal, and anal human papillomavirus 9-valent vaccine Gardasil 9
cancers and dysplasia; genital warts (Types 6, 11, 16, 18, 31, 33, 45, 52, and 58)
Cervical cancer and cervical dysplasia human papillomavirus bivalent vaccine (Types 16 and 18) Cervarix
Condition Generic Name Trade Name
Actinic keratosis ingenol mebutate Picato
fluorouracil Adricil
diclofenac sodium Voltaren
5-aminolevulinic acid + photodynamic therapy (PDT)
masoprocol/nordihydroguaiaretic acid Actinex
Bladder dysplasia bacillus Calmette-Guerin (BCG)
valrubicin Valstar
Esophageal dysplasia porfimer sodium + photodynamic therapy (PDT) Photofrin
*adapted from Wu X, Patterson S, Hawk E. Chemoprevention – History and general principles. Best Practice Research Clinical Gastroenterology. 2011;25:445-59.
Cancer Risk Reduction
Treatment of Precancerous Conditions
FDA-approved Therapeutics for Cancer
Risk Reduction or Treatment
of Precancerous Conditions*
Supplemental
Table 1
